172 related articles for article (PubMed ID: 10343158)
41. Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry.
Kisserli A; Audonnet S; Duret V; Tabary T; Cohen JHM; Mahmoudi R
J Vis Exp; 2020 May; (159):. PubMed ID: 32510517
[TBL] [Abstract][Full Text] [Related]
42. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
[TBL] [Abstract][Full Text] [Related]
43. [Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes. II. E-CR1 levels in patients with various diseases and their correlation with B-CR1].
Itoh Y; Fukunaga Y; Yamamoto M
Arerugi; 1989 Nov; 38(11):1276-87. PubMed ID: 2534036
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.
Fonseca MI; Chu S; Pierce AL; Brubaker WD; Hauhart RE; Mastroeni D; Clarke EV; Rogers J; Atkinson JP; Tenner AJ
PLoS One; 2016; 11(2):e0149792. PubMed ID: 26914463
[TBL] [Abstract][Full Text] [Related]
45. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
46. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
47. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.
Arora V; Mondal AM; Grover R; Kumar A; Chattopadhyay P; Das N
Mol Immunol; 2007 Mar; 44(7):1722-8. PubMed ID: 17049990
[TBL] [Abstract][Full Text] [Related]
48. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
Mitchell JA; Sim RB; Sim E
Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
[TBL] [Abstract][Full Text] [Related]
49. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
Said PB; Sarano J; Manni JA; Casellas AM
Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
[TBL] [Abstract][Full Text] [Related]
50. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome.
Wang FS; Chu FL; Jin L; Li YG; Zhang Z; Xu D; Shi M; Wu H; Moulds JM
Clin Exp Immunol; 2005 Jan; 139(1):112-9. PubMed ID: 15606620
[TBL] [Abstract][Full Text] [Related]
51. [The structure and role of CR1 complement receptor in physiology].
Rochowiak A; Niemir ZI
Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
[TBL] [Abstract][Full Text] [Related]
52. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
[TBL] [Abstract][Full Text] [Related]
53. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals.
Cohen JH; Geffriaud C; Caudwell V; Kazatchkine MD
AIDS; 1989 Jun; 3(6):397-9. PubMed ID: 2568845
[TBL] [Abstract][Full Text] [Related]
54. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
Yuan YD; Zhao MX; Yu J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
[TBL] [Abstract][Full Text] [Related]
55. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).
Csípö I; Kiss E; Soltész P; Antal-Szalmás P; Szegedi G; Cohen JH; Taylor RP; Kávai M
Clin Exp Immunol; 1999 Dec; 118(3):458-64. PubMed ID: 10594568
[TBL] [Abstract][Full Text] [Related]
56. Modulation of urinary CR1 in systemic lupus erythematosus.
Sivasankar B; Dinda AK; Tiwari SC; Srivastava LM; Das N
Lupus; 2004; 13(4):228-33. PubMed ID: 15176657
[TBL] [Abstract][Full Text] [Related]
57. [Changes of genomic density polymorphism and quantitative expression of complement receptor type 1 in patients with liver diseases].
Wang H; Qian B; Niu F; Jiang A
Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):335-7. PubMed ID: 11135688
[TBL] [Abstract][Full Text] [Related]
58. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
Fyfe A; Holme ER; Zoma A; Whaley K
Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of complement receptor type I (CR1, CD35) on erythrocytes in patients with hemoplasma infection.
Congbin Y; Aibin L; Congli Y; Juan X; Lanjun B; Weiping Z; Zhibiao Y; Xiuguo H
Microbiol Immunol; 2010 Aug; 54(8):460-5. PubMed ID: 20646210
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
